Clinical Trials Browser

Phase EARLY_PHASE1 × Cell- and Tissue-Based Therapy × 90 days × Clear all

NCT04744116 2026-04-17

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms